Steven Robert Pacelli

CIK 1359098 · EVP Managing Director Dexcom V · last filed 2023-11-27

Steven Robert Pacelli is an EVP Managing Director Dexcom V who has filed 176 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for DXCM, was dated Apr 23, 2024. Across all open-market trades the lifetime net is −$78.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$10.81M

Companies

2

Total Filings

176

Lifetime Open-Market Net

-$78.36M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

5555 OBERLIN DRIVE
SAN DIEGO, CA 92121

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
DXCM	EVP Managing Director Dexcom V	124,775	$86.67	$10.81M	-$78.36M	160	2023-11-27
ProSomnus, Inc. (OSAAW) Delisted	Director	—	$0.02	—	$0	1	2023-02-02

Recent Filings

176 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-04-23	DXCM	Notice (144)	−500	-$65.7K	EDGAR
2024-03-22	DXCM	Notice (144)	−500	-$66.7K	EDGAR
2024-03-07	DXCM	Notice (144)	−640	-$86.8K	EDGAR
2024-03-06	DXCM	Notice (144)	−4,360	-$565.5K	EDGAR
2024-02-26	DXCM	Notice (144)	−4,500	-$523.6K	EDGAR
2023-11-27	DXCM	Sell (S)	−411	-$45.5K	EDGAR
2023-11-24	DXCM	Notice (144)	−411	-$45.5K	EDGAR
2023-10-23	DXCM	Notice (144)	−411	-$35.2K	EDGAR
2023-10-23	DXCM	Sell (S)	−411	-$35.2K	EDGAR
2023-09-22	DXCM	Notice (144)	−411	-$36.3K	EDGAR

Showing 1–10 of 176

Page 1 of 18 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.